Prothena reported $288.21M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Akebia Therapeutics AKBA:US $ 174.63M 39.26M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
ALKERMES ALKS:US $ 1097.9M 46.75M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amgen AMGN:US $ 8247M 1087M
Biogen BIIB:US $ 10429.9M 322M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Exelixis EXEL:US $ 2043.08M 131.89M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Macrogenics MGNX:US $ 319.04M 31.49M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Prothena PRTA:US $ 288.21M 53.62M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M
Vital Therapies VTL:US $ 120.74M 16.7M
Xoma XOMA:US $ 116.58M 34.86M
YTE INCY:US $ 2935.86M 208.02M